Cancer Family
Female Reproductive System Adnexal Neoplasm
CI-CAN-00000180Explore in graph →
Non-malignant766 active trials5 approved drugs94 evidence items
- NCIt
- C212117
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000180Explore in graph →
Clinical trials
3,477 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00003214 | Chemosensitivity Testing to Assign Treatment for Patients With Stage III or Stage IV Ovarian Cancer | completed | Phase 3 | 300 | Swiss Cancer InstituteOTHER | 1 | May 15, 2019 | clinicaltrials |
| NCT00357448 | Denileukin Diftitox Used in Treating Patients With Advanced Refractory Ovarian Cancer, Primary Peritoneal Carcinoma, or Epithelial Fallopian Tube Cancer | completed | Phase 1 | 11 | University of WashingtonOTHER | 1 | May 14, 2019 | clinicaltrials |
| NCT01556841 | The Activity of TroVax® Versus Placebo in Relapsed Asymptomatic Ovarian Cancer(TRIOC) | completed | Phase 2 | 94 | University College, LondonOTHER | 1 | May 9, 2019 | clinicaltrials |
| NCT00862355 | Bioequivalence Study of SPARC147609 in Patients With Ovarian Cancer | completed | Phase 1 | 24 | Sun Pharma Advanced Research Company LimitedINDUSTRY | 1 | May 3, 2019 | clinicaltrials |
| NCT03863912 | Impact of Disney Movies During Chemotherapy on QOL of Gynecologic Oncology Patients | completed | N/A | 56 | Medical University of ViennaOTHER | 1 | May 3, 2019 | clinicaltrials |
| NCT02569983 | The SOCQER-2 Study Surgery in Ovarian Cancer - Quality of Life Evaluation Research(SOCQER-2) | completed | — | 235 | University of BirminghamOTHER | 1 | May 2, 2019 | clinicaltrials |
| NCT03931304 | Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Carcinomatosis From Ovarian Cancer (Cyto-chip 2)(Cyto-chip 2) | completed | — | 1,200 | Hospices Civils de LyonOTHER | 1 | Apr 30, 2019 | clinicaltrials |
| NCT02351479 | Hula, a Physical Activity Intervention for Female-Cancer Survivors | completed | N/A | 73 | University of HawaiiOTHER | 1 | Apr 18, 2019 | clinicaltrials |
| NCT00011986 | Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer | completed | Phase 3 | 4,312 | Gynecologic Oncology GroupNETWORK | 1 | Apr 16, 2019 | clinicaltrials |
| NCT00088413 | PANVAC-V and PANVAC-F Vaccines Plus Sargramostim to Treat Advanced Cancer | completed | Phase 1 / Phase 2 | 51 | National Cancer Institute (NCI)NIH | 1 | Apr 16, 2019 | clinicaltrials |
| NCT01846611 | A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer | completed | Phase 3 | 581 | Janssen Research & Development, LLCINDUSTRY | 10 | Apr 1, 2019 | clinicaltrials |
| NCT03889171 | Comparison to Psychological, Medical and Emotional Influencing Communication and Achievement Factors to Oncogenetics Tests(PSICOM) | completed | — | 200 | University Hospital, MontpellierOTHER | 0 | Mar 28, 2019 | clinicaltrials |
| NCT02786524 | Effect of Outpatient Symptom Management on Gynecologic Oncology Patients Receiving Chemotherapy | completed | N/A | 107 | University of MichiganOTHER | 1 | Mar 21, 2019 | clinicaltrials |
| NCT00407758 | Enzastaurin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer | completed | Phase 2 | 28 | Gynecologic Oncology GroupNETWORK | 1 | Mar 20, 2019 | clinicaltrials |
| NCT02591095 | A Study of ABT-263 as Single Agent in Women With Platinum Resistant/Refractory Recurrent Ovarian Cancer(MONAVI-1) | completed | Phase 2 | 47 | Centre Francois BaclesseOTHER | 1 | Mar 19, 2019 | clinicaltrials |
| NCT02305498 | Yoga Practice for Breast or Ovarian Cancer Patients | completed | N/A | 39 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 14, 2019 | clinicaltrials |
| NCT01489371 | EGEN-001 and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer | completed | Phase 1 | 16 | Gynecologic Oncology GroupNETWORK | 1 | Mar 12, 2019 | clinicaltrials |
| NCT00496106 | Stress, Immunity and Cervical Cancer: Biobehavioral Outcomes(CXR01) | completed | N/A | 204 | University of California, IrvineOTHER | 1 | Mar 7, 2019 | clinicaltrials |
| NCT02622776 | Advanced Methods for Cancer Detection by Vaginal Screening(ADVISE) | completed | N/A | 122 | Anna TinkerOTHER | 1 | Mar 6, 2019 | clinicaltrials |
| NCT01381861 | Evaluation of TRC105 in the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma | completed | Phase 2 | 23 | Tracon Pharmaceuticals Inc.INDUSTRY | 1 | Mar 5, 2019 | clinicaltrials |
| NCT03562533 | Real-World Effectiveness of PLD in Platinum- Sensitive Recurrent Ovarian Cancer | completed | — | 432 | Konkuk University Medical CenterOTHER | 1 | Feb 28, 2019 | clinicaltrials |
| NCT00003002 | HER-2/Neu Vaccine Plus GM-CSF in Treating Patients With Stage III or Stage IV Breast, Ovarian, or Non-small Cell Lung Cancer | completed | Phase 1 | 60 | University of WashingtonOTHER | 1 | Feb 27, 2019 | clinicaltrials |
| NCT00436501 | VEGF Trap and Docetaxel in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer | completed | Phase 1 / Phase 2 | 58 | National Cancer Institute (NCI)NIH | 1 | Feb 26, 2019 | clinicaltrials |
| NCT02785887 | Impact of Geriatrician Interventions on Chemotherapy Delivery in Vulnerable Elderly Oncology Patients(GIVE) | completed | N/A | 233 | Azienda USL 4 PratoOTHER | 1 | Feb 15, 2019 | clinicaltrials |
| NCT03011320 | An Exploratory Study of the Folic Acid-tubulysin Conjugate EC1456 in Ovarian Cancer Subjects Undergoing Surgery | completed | Phase 1 | 3 | EndocyteINDUSTRY | 2 | Feb 7, 2019 | clinicaltrials |
| NCT00002600 | Combination Chemotherapy, Bone Marrow Transplantation, and Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer | completed | Phase 1 | 23 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Feb 6, 2019 | clinicaltrials |
| NCT01010126 | Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer | completed | Phase 2 | 252 | National Cancer Institute (NCI)NIH | 2 | Jan 25, 2019 | clinicaltrials |
| NCT03551171 | The Clinical Trial to Evaluate the Pharmacokinetics, Safety and Tolerability of ZL-2306 (Niraparib) in Patients With Ovarian Cancer | completed | Phase 1 | 42 | Zai Lab (Shanghai) Co., Ltd.INDUSTRY | 1 | Jan 24, 2019 | clinicaltrials |
| NCT02582931 | MRI-Guided Stereotactic Body Radiation Therapy (SBRT) for Ovarian Cancer | completed | Phase 1 | 10 | Washington University School of MedicineOTHER | 1 | Jan 17, 2019 | clinicaltrials |
| NCT02418624 | Phase I of Carboplatin-Olaparib Followed by Olaparib Monotherapy in Advanced Cancer(REVIVAL) | completed | Phase 1 | 25 | The Netherlands Cancer InstituteOTHER | 1 | Jan 16, 2019 | clinicaltrials |
| NCT00939809 | A6 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer | completed | Phase 2 | 31 | Gynecologic Oncology GroupNETWORK | 1 | Jan 15, 2019 | clinicaltrials |
| NCT03804866 | NGR-hTNF in Combination With an Anthracycline in Platinum-resistant Ovarian Cancer (NGR018) | completed | Phase 2 | 14 | AGC Biologics S.p.A.INDUSTRY | 1 | Jan 15, 2019 | clinicaltrials |
| NCT02585362 | Whey Protein Supplement in Combination With Physical Exercise and Nutrition Program | completed | N/A | 52 | Kantonsspital Winterthur KSWOTHER | 1 | Jan 11, 2019 | clinicaltrials |
| NCT03367182 | Real-World Effectiveness of Bevacizumab Based on AURELIA in Platinum-resistant Recurrent Ovarian Cancer(REBECA) | completed | — | 50 | Yonsei UniversityOTHER | 1 | Jan 11, 2019 | clinicaltrials |
| NCT01286987 | Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors | completed | Phase 1 | 113 | PfizerINDUSTRY | 2 | Jan 10, 2019 | clinicaltrials |
| NCT01434355 | DNA Analysis in Samples From Younger Patients With Germ Cell Tumors and Their Parents or Siblings | completed | — | 932 | Children's Oncology GroupNETWORK | 1 | Jan 7, 2019 | clinicaltrials |
| NCT00628654 | Glycan Analysis in Diagnosing Cancer in Women With Ovarian Epithelial Cancer and in Healthy Female Participants | completed | — | 581 | University of California, DavisOTHER | 1 | Jan 4, 2019 | clinicaltrials |
| NCT01788995 | BOVARI: A Non-Interventional Study of Avastin (Bevacizumab) as Front-Line Treatment in Patients With Ovarian Cancer | completed | — | 63 | Hoffmann-La RocheINDUSTRY | 1 | Jan 3, 2019 | clinicaltrials |
| NCT03042702 | A Phase 2 Study of Kevetrin in Subjects With Ovarian Cancer | completed | Phase 2 | 2 | Innovation Pharmaceuticals, Inc.INDUSTRY | 1 | Dec 27, 2018 | clinicaltrials |
| NCT03779399 | Treg, Th17 Cells, NKT in Epithelial Ovarian Tumor | completed | — | 60 | Medical University of LublinOTHER | 1 | Dec 19, 2018 | clinicaltrials |
| NCT01121640 | A Trial Using Novel Markers to Predict Malignancy in Elevated-Risk Women | completed | N/A | 854 | Fred Hutchinson Cancer CenterOTHER | 1 | Dec 13, 2018 | clinicaltrials |
| NCT01936363 | Trial of Pimasertib With SAR245409 or Placebo in Ovarian Cancer | completed | Phase 2 | 65 | EMD SeronoINDUSTRY | 7 | Dec 12, 2018 | clinicaltrials |
| NCT02960594 | hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse(TRT-001) | completed | Phase 1 | 93 | Inovio PharmaceuticalsINDUSTRY | 1 | Nov 19, 2018 | clinicaltrials |
| NCT03653819 | High Intensity Interval Training (HIIT) for Patients With Cancer-related Lymphedema in the Lower Limbs | completed | N/A | 20 | Herlev and Gentofte HospitalOTHER | 1 | Nov 15, 2018 | clinicaltrials |
| NCT02785731 | Evaluation of Multiple Biomarkers to Estimate Risk of Ovarian Cancer in Patients With a Pelvic Mass. | completed | — | 204 | Angle plcINDUSTRY | 2 | Nov 9, 2018 | clinicaltrials |
| NCT01262040 | Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally Invasive | completed | N/A | 154 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 7, 2018 | clinicaltrials |
| NCT01734746 | Sentinel Node Detection in Clinical Early Stage Ovarian Cancer(SONAR) | completed | N/A | 22 | Maastricht University Medical CenterOTHER | 1 | Nov 5, 2018 | clinicaltrials |
| NCT01669798 | BIBF 1120 in Bevacizumab Resistant, Persistent, or Recurrent Epithelial Ovarian Cancer | completed | Phase 2 | 32 | AA SecordOTHER | 1 | Oct 16, 2018 | clinicaltrials |
| NCT00870233 | Outcomes From Home in Patients Recovering From Major Gynecologic Cancer Surgery: Measuring Symptoms and Health-related Quality of Life | completed | — | 120 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 15, 2018 | clinicaltrials |
Data updated 24 days agoSource updated May 15, 2019source: clinicaltrials